Last $7.54 USD
Change Today +0.27 / 3.71%
Volume 875.2K
PGNX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 2:41 PM 12/18/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David A. Scheinberg M.D., Ph.D.

Director, Member of Cancer Scientific Advisory Board and Chairman of Science & Strategy Committee, Progenics Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 60 board members in 4 different organizations across 6 different industries.

See Board Relationships
58$165,138

Background*

Dr. David A. Scheinberg, M.D., Ph.D. serves as Vincent Astor Chair and Chairman, Molecular Pharmacology and Chemistry Program at Sloan-Kettering Institute. Dr. Scheinberg serves as Chairman, Experimental Therapeutics Center at Memorial Sloan Kettering Cancer Center. He is also Professor of Medicine and Pharmacology and Co-chair of the Pharmacology graduate program at the Weill-Cornell University Medical College and Professor in the Gerstner-Sloan Kettering Graduate School ...

Read Full Background

Corporate Headquarters*

777 Old Saw Mill River Road
Tarrytown, New York 10591

United States

Phone: 914-789-2800
Fax: 914-789-2817

Board Members Memberships*

1996-Present
Director, Member of Cancer Scientific Advisory Board and Chairman of Science & Strategy Committee
2010-Present
Director, Chairman of Compensation Committee and Member of Audit Committee

Education*

BA 1977
Cornell University
PhD 1983
Johns Hopkins School of Medicine
MD 1983
Johns Hopkins School of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options121,607
Total Number of Options121,607

Total Compensation*

Total Annual Cash Compensation$94,610
Total Calculated Compensation$165,138
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PGNX:US $7.54 USD +0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ron Squarer BSc (Biochemistry), MBAChief Executive Officer and Director
Array BioPharma, Inc.
$548.8K
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
$852.8K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROGENICS PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.